packageEverolimus

everolimus

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Everolimus is an mTOR inhibitor used as an antineoplastic and immunosuppressant for cancers such as renal cell carcinoma, breast cancer, and neuroendocrine tumors, as well as tuberous sclerosis. It is authorised in the European Union for several cancer types and tuberous sclerosis, and is an approved drug.

Summary written by glm-5.3-flash from Wikidata Q421052 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:everolimus
ATC codes:L01EG02, L01XE10, L04AH02
DrugBank:DB01590
PubChem CID:6442177
ChEBI:68478
Wikidata:Q421052
formula:C53H83NO14
molar mass:958.24 g/mol (PubChem CID 6442177)
logP:5.9 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown